Suppr超能文献

Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.

作者信息

Li Tingting, Cai Hongmin, Yao Hebang, Zhou Bingjie, Zhang Ning, van Vlissingen Martje Fentener, Kuiken Thijs, Han Wenyu, GeurtsvanKessel Corine H, Gong Yuhuan, Zhao Yapei, Shen Quan, Qin Wenming, Tian Xiao-Xu, Peng Chao, Lai Yanling, Wang Yanxing, Hutter Cedric A J, Kuo Shu-Ming, Bao Juan, Liu Caixuan, Wang Yifan, Richard Audrey S, Raoul Hervé, Lan Jiaming, Seeger Markus A, Cong Yao, Rockx Barry, Wong Gary, Bi Yuhai, Lavillette Dimitri, Li Dianfan

机构信息

State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.

University of CAS, Beijing, China.

出版信息

Nat Commun. 2022 Jul 27;13(1):4359. doi: 10.1038/s41467-022-32074-w.

DOI:10.1038/s41467-022-32074-w
PMID:35896553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9329378/
Abstract
摘要

相似文献

1
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Nat Commun. 2022 Jul 27;13(1):4359. doi: 10.1038/s41467-022-32074-w.
2
A potent neutralizing nanobody against SARS-CoV-2 with inhaled delivery potential.
MedComm (2020). 2021 Mar;2(1):101-113. doi: 10.1002/mco2.60. Epub 2021 Mar 4.
3
Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain.
Chem Biol Drug Des. 2021 Jul;98(1):1-18. doi: 10.1111/cbdd.13847. Epub 2021 May 13.
4
Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.
Nano Lett. 2021 Jun 9;21(11):4774-4779. doi: 10.1021/acs.nanolett.1c01284. Epub 2021 May 25.
5
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19.
MAbs. 2022 Jan-Dec;14(1):2047144. doi: 10.1080/19420862.2022.2047144.
6
MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters.
Front Immunol. 2022 Mar 16;13:845969. doi: 10.3389/fimmu.2022.845969. eCollection 2022.
7
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19.
bioRxiv. 2021 Nov 12:2021.11.10.468147. doi: 10.1101/2021.11.10.468147.
8
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein.
J Nanobiotechnology. 2021 Jan 29;19(1):33. doi: 10.1186/s12951-021-00768-w.
9
An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants.
Signal Transduct Target Ther. 2022 Feb 9;7(1):44. doi: 10.1038/s41392-022-00912-4.
10
Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants.
Front Microbiol. 2022 Jun 2;13:875840. doi: 10.3389/fmicb.2022.875840. eCollection 2022.

引用本文的文献

1
The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics.
Mol Diagn Ther. 2023 Mar;27(2):193-226. doi: 10.1007/s40291-022-00634-x. Epub 2023 Jan 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验